EQS-News: BB Biotech: Strategic reallocation of portfolio assets progressing
BB Biotech: Strategic reallocation of portfolio assets progressing Portfolio of BB Biotech AG as at September 30, 2024 A key event during the period under review was the US Federal Reserve's decision in September to lower interest rates by 50 bps, marking its first rate cut in four years.
| Ticker |
Sentiment |
Impact |
|
BHVN
|
Neutral
|
4 %
|
|
CLDX
|
Neutral
|
4 %
|
|
RLAY
|
Neutral
|
7 %
|
|
EWTX
|
Somewhat Bullish
|
4 %
|
|
NBIX
|
Somewhat Bearish
|
4 %
|
|
WVE
|
Neutral
|
11 %
|
|
ALNY
|
Somewhat Bullish
|
4 %
|
|
VRTX
|
Neutral
|
4 %
|
|
IONS
|
Neutral
|
4 %
|
|
EXEL
|
Neutral
|
4 %
|
